TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 79 filers reported holding TREACE MED CONCEPTS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $127 | -49.0% | 19,081 | +0.0% | 0.00% | – |
| Q1 2024 | $249 | +2.5% | 19,076 | -0.1% | 0.00% | – |
| Q4 2023 | $243 | -5.4% | 19,096 | -2.4% | 0.00% | – |
| Q3 2023 | $257 | -48.2% | 19,572 | +0.9% | 0.00% | -100.0% |
| Q2 2023 | $496 | -11.6% | 19,395 | -13.0% | 0.00% | 0.0% |
| Q1 2023 | $561 | 0.0% | 22,288 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $561 | -99.9% | 24,391 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $538,000 | +54.2% | 24,378 | +0.3% | 0.00% | – |
| Q2 2022 | $349,000 | -24.3% | 24,312 | -0.3% | 0.00% | – |
| Q1 2022 | $461,000 | +99.6% | 24,374 | +96.6% | 0.00% | – |
| Q4 2021 | $231,000 | -9.8% | 12,396 | +30.3% | 0.00% | – |
| Q3 2021 | $256,000 | -12.9% | 9,516 | +1.2% | 0.00% | – |
| Q2 2021 | $294,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 750,000 | $4,987,500 | 2.25% |
| Soleus Capital Management, L.P. | 2,365,648 | $15,731,559 | 1.39% |
| GAGNON SECURITIES LLC | 483,581 | $3,215,814 | 0.72% |
| ARMISTICE CAPITAL, LLC | 5,360,000 | $35,644,000 | 0.45% |
| Divisadero Street Capital Management, LP | 114,400 | $760,760 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 191,427 | $1,273 | 0.09% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 212,976 | $1,416,290 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 526,918 | $3,504,005 | 0.07% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,681,718 | $24,483,425 | 0.06% |
| Lighthouse Investment Partners, LLC | 167,500 | $1,113,875 | 0.04% |